Insider Trading Roundup: Immudyne, Inc. $IMMD

calculator-723925_1920

Immudyne, Inc. (IMMD) insider have most recently took part in a trading activity. On Dec 5, 2017 Schreiber Justin, President, Immudyne PR, 10% Owner bought 25,133 shares having total worth of $9,802 at the price of $0.39 per share, following the transaction a total of 3,393,693 shares owned by Schreiber Justin. Before this latest buy, Schreiber Justin purchased IMMD at 3 other times during the past twelve months, for a total investment of $21,305 at an average of $0.41 per share.

The stock has experienced a total of 3 insider trades in the past three months. These trades include 3 buy trades. Furthermore, over the past 12 months , the stock was traded 3 times by insiders. an employee of the company was the buyer in 3 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 3 0 -12.53%
12 Month 3 0 39.62%

Shares of Immudyne, Inc. (IMMD) traded down 6.92% on Dec 5, 2017, hitting $0.36. 101,725 shares of the company’s stock traded hands. Immudyne, Inc. has a 52 week low of $0.21 and a 52 week high of $0.79. The company’s market cap is $0 million.

Immudyne, Inc., manufacture, distribute and sell natural immune support products. The product of the company include ‘Beta glucans’ which is biological response modifiers that support the immune system.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.